Ledger.Open graph →
SEC Form D · filed June 6, 2018

Mirata Pharmaceuticals, LLC

Offering
$6.5M
Sold
$3.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PLYMOUTH MEETING, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Maurits Geerlings · Plymouth Meeting, PADirectorMatthew Callahan · Plymouth Meeting, PAExec · DirectorJonathan Ord · Provo, UTExec · DirectorNathan Morris · Provo, UTDirectorGreg Bell · TAMPA, FLDirectorPaul Labarre · TAMPA, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗